Published in BMJ on February 18, 1995
CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ (2010) 28.70
Estimation of the warfarin dose with clinical and pharmacogenetic data. N Engl J Med (2009) 12.63
Confidence intervals for the number needed to treat. BMJ (1998) 9.59
Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med (2009) 8.25
EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis (2006) 6.36
Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat (2012) 5.35
Calculating the number needed to treat for trials where the outcome is time to an event. BMJ (1999) 5.06
Numbers needed to treat derived from meta-analyses--sometimes informative, usually misleading. BMJ (1999) 4.94
EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis (2004) 4.94
Evidence based purchasing: understanding results of clinical trials and systematic reviews. BMJ (1995) 4.75
Topical NSAIDs for acute pain in adults. Cochrane Database Syst Rev (2010) 4.35
ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis (2005) 4.31
Implicit value judgments in the measurement of health inequalities. Milbank Q (2010) 4.14
Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review. BMJ (2001) 3.76
Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis. CMAJ (2008) 3.56
Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men. Heart (1999) 3.53
Seeing what you want to see in randomised controlled trials: versions and perversions of UKPDS data. United Kingdom prospective diabetes study. BMJ (2000) 2.96
Home based exercise programme for knee pain and knee osteoarthritis: randomised controlled trial. BMJ (2002) 2.90
The number needed to treat: a clinically useful nomogram in its proper context. BMJ (1996) 2.89
Aspirin with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev (2010) 2.77
EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis (2006) 2.75
Cost effectiveness of HMG-CoA reductase inhibitor (statin) treatment related to the risk of coronary heart disease and cost of drug treatment. Heart (1999) 2.69
Efficacy and harm of pharmacological prevention of acute mountain sickness: quantitative systematic review. BMJ (2000) 2.68
Quantification of survival gain from cardiac resynchronization therapy: nonlinear growth with time, and greater gain in low-risk patients, make raw trial data an underestimate of real-world behavior. J Am Coll Cardiol (2013) 2.66
Does paracetamol (acetaminophen) reduce the pain of osteoarthritis? A meta-analysis of randomised controlled trials. Ann Rheum Dis (2004) 2.64
Communicating the risk reduction achieved by cholesterol reducing drugs. BMJ (1998) 2.59
The effects of information framing on the practices of physicians. J Gen Intern Med (1999) 2.52
Patients' responses to risk information about the benefits of treating hypertension. Br J Gen Pract (2001) 2.50
Evidence-based medicine: a commentary on common criticisms. CMAJ (2000) 2.48
Boosting uptake of influenza immunisation: a randomised controlled trial of telephone appointing in general practice. Br J Gen Pract (2002) 2.41
Comparison of evidence on harms of medical interventions in randomized and nonrandomized studies. CMAJ (2006) 2.40
The performance of different propensity-score methods for estimating differences in proportions (risk differences or absolute risk reductions) in observational studies. Stat Med (2010) 2.39
Efficacy of topical non-steroidal anti-inflammatory drugs in the treatment of osteoarthritis: meta-analysis of randomised controlled trials. BMJ (2004) 2.39
The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments. Stat Med (2013) 2.32
What should we say to patients with symptoms unexplained by disease? The "number needed to offend". BMJ (2002) 2.20
Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis. CMAJ (2003) 2.18
Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm. JAMA Psychiatry (2015) 2.17
Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev (2011) 2.13
Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial. Lancet Respir Med (2015) 2.12
Guidelines for managing raised blood pressure. BMJ (1996) 2.03
Disease impact number and population impact number: population perspectives to measures of risk and benefit. BMJ (2000) 1.99
Compulsory community and involuntary outpatient treatment for people with severe mental disorders. Cochrane Database Syst Rev (2011) 1.95
Applying the results of clinical trials to patients to general practice: perceived problems, strengths, assumptions, and challenges for the future. Br J Gen Pract (1998) 1.88
Identifying patient preferences for communicating risk estimates: a descriptive pilot study. BMC Med Inform Decis Mak (2001) 1.88
Topical capsaicin for chronic neuropathic pain in adults. Cochrane Database Syst Rev (2009) 1.88
Topical NSAIDs for chronic musculoskeletal pain in adults. Cochrane Database Syst Rev (2012) 1.86
Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial. BMJ (2004) 1.84
Single dose oral paracetamol (acetaminophen) for postoperative pain in adults. Cochrane Database Syst Rev (2008) 1.81
Competing risks and the clinical community: irrelevance or ignorance? Stat Med (2011) 1.80
Single dose oral paracetamol (acetaminophen) with codeine for postoperative pain in adults. Cochrane Database Syst Rev (2009) 1.77
Anticonvulsant drugs for management of pain: a systematic review. BMJ (1995) 1.70
Current evidence for the management of ankylosing spondylitis: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis. Ann Rheum Dis (2005) 1.70
The science of perpetual change. Br J Gen Pract (1996) 1.69
Interpreting treatment effects from clinical trials in the context of real-world risk information: end-stage renal disease prevention in older adults. JAMA Intern Med (2014) 1.68
Meta-analysis, Simpson's paradox, and the number needed to treat. BMC Med Res Methodol (2002) 1.66
Does improving maternal knowledge of vaccines impact infant immunization rates? A community-based randomized-controlled trial in Karachi, Pakistan. BMC Public Health (2011) 1.64
Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: systematic review and meta-analysis of information from company clinical trial reports. Arthritis Res Ther (2005) 1.63
Single dose oral ibuprofen for acute postoperative pain in adults. Cochrane Database Syst Rev (2009) 1.63
Systematic review of the use of honey as a wound dressing. BMC Complement Altern Med (2001) 1.63
Topical NSAIDs for chronic musculoskeletal pain: systematic review and meta-analysis. BMC Musculoskelet Disord (2004) 1.61
An evidence-based update on nonsteroidal anti-inflammatory drugs. Clin Med Res (2007) 1.57
Misoprostol in patients taking non-steroidal anti-inflammatory drugs. BMJ (1995) 1.54
Absolute risk reduction in osteoporosis: assessing treatment efficacy by number needed to treat. Rheumatol Int (2009) 1.53
Prophylactic Ankle Taping and Bracing: A Numbers-Needed-to-Treat and Cost-Benefit Analysis. J Athl Train (2004) 1.52
Brief motivational and parent interventions for college students: a randomized factorial study. J Consult Clin Psychol (2010) 1.49
Imiquimod for the treatment of genital warts: a quantitative systematic review. BMC Infect Dis (2001) 1.47
Topical NSAIDs for acute pain: a meta-analysis. BMC Fam Pract (2004) 1.45
Triptans for acute cluster headache. Cochrane Database Syst Rev (2010) 1.43
Single dose oral naproxen and naproxen sodium for acute postoperative pain. Cochrane Database Syst Rev (2004) 1.41
Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice. Ann Rheum Dis (2009) 1.40
The effect of statins on average survival in randomised trials, an analysis of end point postponement. BMJ Open (2015) 1.39
Single dose oral diclofenac for acute postoperative pain in adults. Cochrane Database Syst Rev (2009) 1.39
Local anaesthetics and regional anaesthesia for preventing chronic pain after surgery. Cochrane Database Syst Rev (2012) 1.33
Communicating risks at the population level: application of population impact numbers. BMJ (2003) 1.30
Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials. BMC Neurol (2008) 1.28
A tutorial on methods to estimating clinically and policy-meaningful measures of treatment effects in prospective observational studies: a review. Int J Biostat (2011) 1.28
Getting research findings into practice. When to act on the evidence. BMJ (1998) 1.26
Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials. BMC Fam Pract (2000) 1.26
Enriched enrollment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review. Br J Clin Pharmacol (2008) 1.25
Calculation of NNTs in RCTs with time-to-event outcomes: a literature review. BMC Med Res Methodol (2009) 1.24
The role of opioid prescription in incident opioid abuse and dependence among individuals with chronic noncancer pain: the role of opioid prescription. Clin J Pain (2014) 1.19
[Recommendations for the management of ankylosing spodylitis after ASAS/EULAR. Evaluation in the German language area]. Z Rheumatol (2006) 1.18
Meta-analysis of randomised controlled trials comparing latanoprost with timolol in the treatment of patients with open angle glaucoma or ocular hypertension. Br J Ophthalmol (2001) 1.15
Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritis. Arthritis Res Ther (2006) 1.15
Ethnicity-specific pharmacogenetics: the case of warfarin in African Americans. Pharmacogenomics J (2013) 1.14
Regional anaesthesia to prevent chronic pain after surgery: a Cochrane systematic review and meta-analysis. Br J Anaesth (2013) 1.13
A general binomial regression model to estimate standardized risk differences from binary response data. Stat Med (2012) 1.12
Treatment of oppositional defiant and conduct problems in young Norwegian children : results of a randomized controlled trial. Eur Child Adolesc Psychiatry (2008) 1.12
Detecting moderator effects using subgroup analyses. Prev Sci (2013) 1.11
Implementing guidelines in primary care: can population impact measures help? BMC Public Health (2003) 1.10
Carbamazepine for acute and chronic pain in adults. Cochrane Database Syst Rev (2011) 1.10
Number needed to treat (NNT): implication in rheumatology clinical practice. Ann Rheum Dis (2003) 1.09
Systematic review of dexketoprofen in acute and chronic pain. BMC Clin Pharmacol (2008) 1.09
Effects of information framing on the intentions of family physicians to prescribe long-term hormone replacement therapy. J Gen Intern Med (1999) 1.09
Will screening mammography in the East do more harm than good? Am J Public Health (2002) 1.08
Prophylactic antiepileptic agents after head injury: a systematic review. J Neurol Neurosurg Psychiatry (1998) 1.08
Treatment of established postoperative nausea and vomiting: a quantitative systematic review. BMC Anesthesiol (2001) 1.07
Finasteride in the treatment of clinical benign prostatic hyperplasia: a systematic review of randomised trials. BMC Urol (2002) 1.06
Sumatriptan (oral route of administration) for acute migraine attacks in adults. Cochrane Database Syst Rev (2012) 1.05
Evidence-based medicine. A new approach to teaching the practice of medicine. JAMA (1992) 37.26
Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet (1990) 24.72
An assessment of clinically useful measures of the consequences of treatment. N Engl J Med (1988) 13.02
Who benefits from medical interventions? BMJ (1994) 5.58
Evidence based medicine: what it is and what it isn't. BMJ (1996) 66.70
Inpatient general medicine is evidence based. A-Team, Nuffield Department of Clinical Medicine. Lancet (1995) 24.14
Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med (1991) 18.33
The Burlington randomized trial of the nurse practitioner. N Engl J Med (1974) 17.02
Bias in analytic research. J Chronic Dis (1979) 16.40
A controlled trial of teaching critical appraisal of the clinical literature to medical students. JAMA (1987) 14.20
An assessment of clinically useful measures of the consequences of treatment. N Engl J Med (1988) 13.02
Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med (1998) 11.27
Increased absenteeism from work after detection and labeling of hypertensive patients. N Engl J Med (1978) 9.29
Controversy in the detection of disease. Lancet (1975) 7.85
How to keep up with the medical literature: V. Access by personal computer to the medical literature. Ann Intern Med (1986) 7.36
Controversy in counting and attributing events in clinical trials. N Engl J Med (1979) 7.25
Randomised clinical trial of strategies for improving medication compliance in primary hypertension. Lancet (1975) 7.22
Users' guides to the medical literature. I. How to get started. The Evidence-Based Medicine Working Group. JAMA (1993) 6.83
A utility maximization model for evaluation of health care programs. Health Serv Res (1972) 6.67
Paclitaxel-resistant human ovarian cancer cells have mutant beta-tubulins that exhibit impaired paclitaxel-driven polymerization. J Biol Chem (1997) 5.51
Users' guides to the medical literature. IX. A method for grading health care recommendations. Evidence-Based Medicine Working Group. JAMA (1995) 5.28
Problems in the handling of clinical and research evidence by medical practitioners. Arch Intern Med (1983) 5.16
A randomized trial of continuing medical education. N Engl J Med (1982) 4.95
Improvement of medication compliance in uncontrolled hypertension. Lancet (1976) 4.84
The Burlington randomized trial of the nurse practitioner: health outcomes of patients. Ann Intern Med (1974) 4.37
The utility of different health states as perceived by the general public. J Chronic Dis (1978) 3.65
An empirical demonstration of Berkson's bias. J Chronic Dis (1978) 3.48
Can simple clinical measurements detect patient noncompliance? Hypertension (1981) 3.29
Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation (1996) 3.23
Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest (1986) 3.16
p53 is associated with cellular microtubules and is transported to the nucleus by dynein. Nat Cell Biol (2000) 3.05
Does a mailed continuing education program improve physician performance? Results of a randomized trial in antihypertensive care. JAMA (1986) 3.04
Choosing the best research design for each question. BMJ (1998) 3.03
Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. N Engl J Med (1986) 3.00
The measurement iterative loop: a framework for the critical appraisal of need, benefits and costs of health interventions. J Chronic Dis (1985) 2.96
How to keep up with the medical literature: I. Why try to keep up and how to get started. Ann Intern Med (1986) 2.94
Quality-of-care appraisal in primary care: a quantitative method. Ann Intern Med (1975) 2.87
Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest (1992) 2.81
Centrosome amplification and instability occurs exclusively in aneuploid, but not in diploid colorectal cancer cell lines, and correlates with numerical chromosomal aberrations. Genes Chromosomes Cancer (2000) 2.73
Methodologic guidelines for systematic reviews of randomized control trials in health care from the Potsdam Consultation on Meta-Analysis. J Clin Epidemiol (1995) 2.73
The development and application of indices of health: general methods and a summary of results. Am J Public Health (1977) 2.53
Clinical recommendations using levels of evidence for antithrombotic agents. Chest (1995) 2.52
Using research findings in clinical practice. BMJ (1998) 2.40
The rational clinical examination. Does this patient have a clinically important carotid bruit? JAMA (1993) 2.38
The rational clinical examination. Does this patient have splenomegaly? JAMA (1993) 2.38
Marginal analysis of recurrent events and a terminating event. Stat Med (1997) 2.36
Hypertension in a family practice. Can Med Assoc J (1977) 2.36
Rules of evidence and clinical recommendations for the management of patients. Can J Cardiol (1993) 2.11
When was a "negative" clinical trial big enough? How many patients you needed depends on what you found. Arch Intern Med (1985) 2.11
Transferring evidence from research into practice: 1. The role of clinical care research evidence in clinical decisions. ACP J Club (1996) 2.10
Cost effectiveness of clinical diagnosis, venography, and noninvasive testing in patients with symptomatic deep-vein thrombosis. N Engl J Med (1981) 2.04
Guidelines for managing raised blood pressure. BMJ (1996) 2.03
Cardiovascular diseases. Lancet (1974) 1.85
Fenoterol and fatal asthma. Lancet (1990) 1.77
Labelling in hypertension: a review of the behavioural and psychological consequences. J Chronic Dis (1984) 1.75
How to keep up with the medical literature: IV. Using the literature to solve clinical problems. Ann Intern Med (1986) 1.75
Cochrane Collaboration. BMJ (1994) 1.74
Educational package on hypertension for primary care physicians. Can Med Assoc J (1984) 1.73
Tubulin subunit carboxyl termini determine polymerization efficiency. J Biol Chem (1985) 1.73
Odds ratios should be avoided when events are common. BMJ (1998) 1.71
Clinical diagnosis and the clinical laboratory. Clin Invest Med (1978) 1.67
Combined use of leg scanning and impedance plethysmography in suspected venous thrombosis. An alternative to venography. N Engl J Med (1977) 1.66
Understanding clinical trials. BMJ (1994) 1.59
How to keep up with the medical literature: II. Deciding which journals to read regularly. Ann Intern Med (1986) 1.57
Tubulin, hybrid dimers, and tubulin S. Stepwise charge reduction and polymerization. J Biol Chem (1985) 1.54
On the need for evidence-based medicine. Health Econ (1996) 1.53
Evaluation of neonatal-intensive-care program. N Engl J Med (1981) 1.52
Cancer risk in ulcerative colitis: scientific requirements for the study of prognosis. Gastroenterology (1980) 1.50
The fall of "clinical research" and the rise of "clinical-practice research". Clin Invest Med (2000) 1.50
The science of the art of the clinical examination. JAMA (1992) 1.48
Self-recording of blood pressure in the management of hypertension. Can Med Assoc J (1978) 1.46
The usefulness of laboratory tests in health-screening programs. Clin Chem (1973) 1.45
Applying the results of trials and systematic reviews to individual patients. ACP J Club (1998) 1.45
Concordance for coronary risk factors among spouses. Circulation (1975) 1.44
Non-use and misuse of measles vaccine. Can Fam Physician (1973) 1.40
1965-1990: 25th anniversary of nurse practitioners. A classic manuscript reprinted in celebration of 25 years of progress. The Burlington randomized trial of the nurse practitioner. 1971-2. J Am Acad Nurse Pract (1990) 1.38
Thrombolytic agents: the science of the art of choosing the better treatment. Ann Intern Med (1994) 1.36
Therapeutic priorities of Canadian internists. CMAJ (1990) 1.33
Patient compliance with antihypertensive regimens. Patient Couns Health Educ (1978) 1.31
Grades of recommendation for antithrombotic agents. Chest (1998) 1.30
Determining causation--a case study: adrenocorticosteroids and osteoporosis. Should the fear of inducing clinically important osteoporosis influence the decision to prescribe adrenocorticosteroids? J Chronic Dis (1984) 1.29
What proportion of primary psychiatric interventions are based on evidence from randomised controlled trials? Qual Health Care (1996) 1.28
Time to put the Canadian Institutes of Health Research on trial. CMAJ (1999) 1.26
Manipulation of the therapeutic regimen to improve compliance: conceptions and misconceptions. Clin Pharmacol Ther (1977) 1.25
Proteolysis of tubulin and the substructure of the tubulin dimer. J Biol Chem (1986) 1.24
Relation between aortic atherosclerosis and the use of cigarettes and alcohol. An autopsy study. N Engl J Med (1968) 1.23
Active-control equivalence trials and antihypertensive agents. Am J Med (2001) 1.23
Compliance with antihypertensive drug therapy. Ann N Y Acad Sci (1978) 1.23
On the need for evidence-based medicine. Therapie (1996) 1.23
Familial aggregation of blood pressure. Preliminary report. JAMA (1966) 1.18
Hypertension II. Finding hypertensives and linking them to clinical care. Can J Public Health (1980) 1.18
Screening in family practice: prevention, levels of evidence, and the pitfalls of common sense. J Fam Pract (1987) 1.16
Pulmonary embolism in outpatients with pleuritic chest pain. Arch Intern Med (1988) 1.14
Teaching critical appraisal: no quick fixes. CMAJ (1998) 1.14
How to keep up with the medical literature: III. Expanding the number of journals you read regularly. Ann Intern Med (1986) 1.14
Effects of labelling on income, work and social function among hypertensive employees. J Chronic Dis (1984) 1.13